UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises

Current opinion in pharmacology, 2008-08, Vol.8 (4), p.393-412

2008

Volltextzugriff (PDF)

Sports Injuries of the Elbow

1st Edition 2021, 2020

Volltextzugriff (PDF)

The cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of cyclin D1, and activates the mitogen-activated protein kinase pathway

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.262-272

2004

Volltextzugriff (PDF)

CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Clinical cancer research, 2012-10, Vol.18 (20), p.5650-5661

2012

Volltextzugriff (PDF)

Sports Injuries of the Shoulder

1st ed. 2020., 2019

Volltextzugriff (PDF)

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Clinical cancer research, 2012-07, Vol.18 (14), p.3912-3923

2012

Volltextzugriff (PDF)

Boundary Thinking Transformed

Parks stewardship forum, 2023-01, Vol.39 (1), p.18-25

Walton, Mike

2023

Volltextzugriff (PDF)

Sports Injuries of the Hand and Wrist

1st ed. 2019., 2019

Volltextzugriff (PDF)

Survivorship of Allologous Structural Bone Graft at a Minimum of 2 Years When Used to Address Significant Glenoid Bone Loss in Revision Shoulder Arthroplasty: A Computed Tomographic and Clinical Review

Journal of shoulder and elbow arthroplasty, 2023, Vol.7, p.24715492231172371-24715492231172371

2023

Volltextzugriff (PDF)

AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth

Molecular cancer therapeutics, 2010-05, Vol.9 (5), p.1100-1110

2010

Volltextzugriff (PDF)

The Management of Frozen Shoulder

Current physical medicine and rehabilitation reports, 2015-06, Vol.3 (2), p.181-187

2015

Volltextzugriff (PDF)

An evaluation of the ability of pifithrin-α and -β to inhibit p53 function in two wild-type p53 human tumor cell lines

Molecular cancer therapeutics, 2005-09, Vol.4 (9), p.1369-1377

2005

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors

Bioorganic & medicinal chemistry, 2011-11, Vol.19 (22), p.6949-6965

2011

Volltextzugriff (PDF)

Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAG) in human colon Cancer models

JNCI : Journal of the National Cancer Institute, 2003-11, Vol.95 (21), p.1624-1633

2003

Volltextzugriff (PDF)

CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells

Cancer research (Chicago, Ill.), 2020-04, Vol.80 (8), p.1735-1747

2020

Volltextzugriff (PDF)

A prospective radiostereometric analysis of the stability of a metal-backed glenoid component/autograft composite in reverse shoulder arthroplasty

The bone & joint journal, 2023-08, Vol.105-B (8), p.912-919

2023

Volltextzugriff (PDF)

Determinants of Customer Loyalty in a Cloud Computing Environment

International journal of cloud applications and computing, 2022-08, Vol.12 (1), p.1-21

2022

Volltextzugriff (PDF)

Radical Versus Incremental Product Changes as Moderator for NPD Success

S.A.M. advanced management journal (1984), 2022-06, Vol.87 (3), p.14

2022

Volltextzugriff (PDF)

An Expanded Model of Success Factors for NPD Performance

International journal of innovation and technology management, 2019-11, Vol.16 (7)

2019

Volltextzugriff (PDF)

Abstract 2384: Investigating mechanisms of tolerance to APOBEC3B upregulation in cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.2384-2384

2020

Volltextzugriff (PDF)

PRP for Arthroscopic Repair of Medium to Large Rotator Cuff Tears: Letter to the Editor

The American journal of sports medicine, 2016-02, Vol.44 (2), p.NP6-NP7

2016

Volltextzugriff (PDF)

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

Clinical cancer research, 2011-03, Vol.17 (6), p.1561-1570

2011

Volltextzugriff (PDF)

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

Investigational new drugs, 2012-02, Vol.30 (1), p.341-349

2012

Volltextzugriff (PDF)

Sports Injuries of the Elbow

2020

Volltextzugriff (PDF)

Abstract 293: Screening the druggable genome for synthetic lethal interactions with the CHK1 inhibitor PNT737

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.293-293

2017

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(197)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises

Sports Injuries of the Elbow

The cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of cyclin D1, and activates the mitogen-activated protein kinase pathway

CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Sports Injuries of the Shoulder

AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Boundary Thinking Transformed

Sports Injuries of the Hand and Wrist

Survivorship of Allologous Structural Bone Graft at a Minimum of 2 Years When Used to Address Significant Glenoid Bone Loss in Revision Shoulder Arthroplasty: A Computed Tomographic and Clinical Review

AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth

The Management of Frozen Shoulder

An evaluation of the ability of pifithrin-α and -β to inhibit p53 function in two wild-type p53 human tumor cell lines

Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors

Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAG) in human colon Cancer models

CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells

A prospective radiostereometric analysis of the stability of a metal-backed glenoid component/autograft composite in reverse shoulder arthroplasty

Determinants of Customer Loyalty in a Cloud Computing Environment

Radical Versus Incremental Product Changes as Moderator for NPD Success

An Expanded Model of Success Factors for NPD Performance

Abstract 2384: Investigating mechanisms of tolerance to APOBEC3B upregulation in cancer

PRP for Arthroscopic Repair of Medium to Large Rotator Cuff Tears: Letter to the Editor

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma

Sports Injuries of the Elbow

Abstract 293: Screening the druggable genome for synthetic lethal interactions with the CHK1 inhibitor PNT737

Suchergebnisse filtern